cells, and directly reprogrammed fibroblasts all provide potentially valuable sources of replacement neurons for cell-based therapies. However, the relatively recent development of direct reprogramming strategies has…
dissect cellular components modulating RNAi using chemical biology approach, we have previously developed a cell-based assay to monitor the activity of the RNAi pathway. Several potent RNAi enhancers have
patients with such degenrations. The recent use of stem cell-derived RPE as a cell-based therapy has provided hope for a therapeutic intervention. The current methods for RPE differentiation
some untreatable human diseases. In addition, stem cell therapy is suitable for developing new cell-based drugs for the future molecular and regenerative medicine
them are more potent than all existing β-catenin/Tcf inhibitors, and exhibit good cell-based activity to human colorectal cancer cell line and selectivity over normal cells
impairment of bone marrow derived endothelial progenitor cells remains an important barrier for cardiac cell-based therapies. Our aim was to create a relevant swine model of chronic ischemia
repair of damaged endothelium. The implementation of EPCs is emerging as a new promising cell-based therapy for restoration of angiogenic activity in cardiovascular disease, which might be particularly beneficial
rapid and reliable measurement of many samples for multiple parameters in cell-free and cell-based assay configurations in parallel rather than consecutive fashion
infections and malignancy. In this review, we will focus on recent advances in NKT cell-based vaccination strategies. Given the role that NKT cells play in autoimmune disease, infectious diseases
expression of DNRII reduced TGF-β sensitivity of the NMuMG-ST cells in various cell-based assays. The blockade of autocrine TGF-β signaling reduced the ability of the cell
against heart failure are symptom-based, short-term and do not prolong survival. Stem cell-based therapy is promising strategy to lead to cardiac repair after MI. Over the last
ipilimumab, an antibody against the cytotoxic Tlymphocyte antigen 4 (CTLA-4), with a cell-based vaccine transfected with the granulocyte macrophage colony-stimulating factor (GM-CSF) gene in advanced refractory
central nervous system (CNS) injury. Thus, these cells represent a new approach to cell-based therapies. The present study examined whether human ASCs (hASCs) could protect a mouse model
attracted attention as useful technique for tissue engineering or regenerative medicine research and cell-based assay studies. Although spheroids are generated using floating culture method on non-adhesive surface
Clin Oncol, 2007). Treatments applied to manage complications of radiotherapy are only symptomatic. Stem cell-based approaches using mesenchymal stem cells (MSCs) are promising for the development of future therapy
crucial role in both stem cell self-renewal and diff erentiation. In stem cell-based therapies, proper regulation of self-renewal and diff erentiation determines the outcome of tissue regeneration
stem cells appears to be a critical parameter in the eff ectiveness of stem cell-based tissue repair. On this basis, Endogenous Stem Cell Mobilization (ESCM) emerges as a possible
stem cells appears to be a critical parameter in the eff ectiveness of stem cell-based tissue repair. On this basis, Endogenous Stem Cell Mobilization (ESCM) emerges as a possible
stem cells appears to be a critical parameter in the eff ectiveness of stem cell-based tissue repair. On this basis, Endogenous Stem Cell Mobilization (ESCM) emerges as a possible
Currently, there are many promising clinical trials using mesenchymal stem cells (MSCs) in cell-based therapies of diseases ranging widely from graft -versus-host to joint and cartilage disorders. Increasingly
chondrocytes in monolayer cultures. Overview of Literature: Biological repair of IVDs by cell-based therapy has been shown to be feasible in clinical trials. As one of the most promising
gene products. Furthermore, our data provide proof for the use of genetically modified stem cell-based gene therapy through a targeted delivery of therapeutic gene products to endometrial cancer sites
improvement in myocardial function. Although multiple experimental animal models and clinical trials of cell-based cardiac therapy have delivered promising results, the mechanisms of their effect are unclear. SC…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.